Both chemokines, s-CXCL16 and s-CX3CL1, significantly enhanced proliferation of classical receptor-negative, tm-chemokine-positive cells like U343 or A764 glioma cells, whereas double-negative cells like LOX melanoma cells did not respond. Here, CXCL16 is linked to melanoma.